These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4637685)

  • 21. [Glipizide, a new sulfonylurea in the treatment of diabetes mellitus].
    Villaseñor A
    Prensa Med Mex; 1973; 38(5):211-4. PubMed ID: 4782089
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic value of a new hypoglycemic agent (gliclazide) in the treatment of diabetes mellitus].
    Polosa P; Mughini L
    Clin Ter; 1978 Jan; 84(2):135-40. PubMed ID: 648096
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].
    Ninni M; Castelletta L
    Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364
    [No Abstract]   [Full Text] [Related]  

  • 24. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). II. Proof of activity in the management of adult onset diabetes].
    Blumenbach L; Kiesselbach NH; Lehnert J
    Arzneimittelforschung; 1974 Mar; 24(0):437-46. PubMed ID: 4603692
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic value of a new original oral antidiabetic with vascular action: gliclazide (SE-1702)].
    Canivet J
    Therapeutique; 1972; 48(7):457-62. PubMed ID: 4640264
    [No Abstract]   [Full Text] [Related]  

  • 26. [New aspects of the treatment of diabetic retinopathy].
    Regnault F; Barre Y; Rietzler X; Foucquier E; Aubert P; Molinier A; Zara M
    Therapeutique; 1973; 49(7):505-7. PubMed ID: 4595363
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic value of a new oral antidiabetic agent: gliclazide].
    Bernasconi D; Mazzi C
    Clin Ter; 1978 Mar; 84(6):627-35. PubMed ID: 648108
    [No Abstract]   [Full Text] [Related]  

  • 29. A clinical trial of glibornuride in maturity-onset diabetes mellitus.
    Tandhanand S; Vannasaeng S; Aswapokee N; Soongsavang V; Aphonsuvan S
    J Med Assoc Thai; 1974 May; 57(5):232-6. PubMed ID: 4832761
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mechanism of the antidiabetic action of sulfanylurea derivatives].
    Iaroshevskiĭ IuA; Volkova EA
    Klin Med (Mosk); 1982 Oct; 60(10):94-7. PubMed ID: 6757562
    [No Abstract]   [Full Text] [Related]  

  • 31. [New oral hypoglycemic agent: K 4024 or glipizide. Clinical trial].
    Angeli G; Baraldi B; Tiraboschi L; Caputo G
    Clin Ter; 1972 Dec; 63(5):438-52. PubMed ID: 4566419
    [No Abstract]   [Full Text] [Related]  

  • 32. [Glibornurid in treatment of diabetes mellitus].
    Rojszykowa E; Wrzesimski W
    Pol Tyg Lek; 1974 Jan; 29(2):63-6. PubMed ID: 4820789
    [No Abstract]   [Full Text] [Related]  

  • 33. [Three-year experience with the antidiabetic glibornurid (Glutril)].
    Hammerl H; Henk W; Köhn H; Kränzl C; Pichler O; Studlar M
    Wien Med Wochenschr; 1974 Jul; 124(27):448-52. PubMed ID: 4210108
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563)].
    Leubner H
    Wien Med Wochenschr; 1973 Apr; 123(17):277-82. PubMed ID: 4574026
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of diabetes mellitus with glibornurid].
    Vignati E; Liuzzi A; Chiodini PG
    Minerva Med; 1973 Oct; 64(75):3900-6. PubMed ID: 4767761
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical trial with a new oral antidiabetic, gliclazid, in general practice (author's transl)].
    Villiger U
    Schweiz Rundsch Med Prax; 1982 Apr; 71(16):699-704. PubMed ID: 7050960
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
    Grzeszczak W; Strojek K
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():38-9. PubMed ID: 8516206
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experiences with gliquidon].
    Schwedes U; Althoff P; Happ J; Petzoldt R; Usadel KH; Beyer J; Schöffling K
    Med Welt; 1978 Feb; 29(5):191-6. PubMed ID: 628335
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical experimentation with a new hypoglycemic agent (glipizide)].
    Forattini C
    Minerva Med; 1972 Oct; 63(70):3816-21. PubMed ID: 4562437
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I; Madsen SN
    Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.